Published date: 17 September 2021
This notice was replaced on 17 September 2021
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 17 September 2021)
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£441,994,547
Procurement reference
CF-0345200D0O000000rwimUAA1
Published date
17 September 2021
Closing date
4 June 2021
Closing time
1pm
Contract start date
1 September 2021
Contract end date
31 August 2023
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
NHS Framework Agreement, Branded Medicines for London and South of England
Offer reference number: CM/PHR/20/5598
FIND A TENDER (FTS) Reference number: FTS-002229
CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B.
Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A.
Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B.
Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche.
Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions - Bevacizumab Period of Framework: 1 September 2021 to 28 February 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months
Award information
Awarded date
19 August 2021
Contract start date
1 September 2021
Contract end date
31 August 2023
Total value of contract
£558,521,926
This contract was awarded to 42 suppliers.
Dr.Reddy's Laboratories (UK) Limited
Address
, Beverley
Reference
None
Supplier is SME?
Yes
Accord-UK Ltd
Address
, Devon
Reference
None
Techdow Pharma England Ltd
Address
, Guildford
Reference
None
Supplier is SME?
Yes
UL Global Pharma
Address
, Hertfordshire
Reference
None
Supplier is SME?
Yes
Biogen
Address
, Maidenhead
Reference
None
Amgen Ltd
Address
, Cambridge
Reference
None
Thornton and Ross Ltd
Address
, Huddersfield
Reference
None
Merck Sharpe & Dohme (UK) Limited
Address
, London
Reference
None
Bayer Ltd
Address
, Reading
Reference
None
Zentiva Pharma UK Ltd
Address
, London
Reference
None
Napp Pharmaceuticals Ltd
Address
, Cambridge
Reference
None
Novo Nordisk
Address
, Gatwick
Reference
None
Daiichi Sankyo UK Ltd
Address
, Uxbridge
Reference
None
Gedeon Richter UK Ltd
Address
, Maida Vale
Reference
None
Supplier is SME?
Yes
Teva UK Limited
Address
, Castleford
Reference
None
Pfizer Ltd
Address
, Kent
Reference
None
Roche Products Ltd
Address
, Garden City
Reference
None
Janssen-Cilag Ltd
Address
, High Wycombe
Reference
None
Mylan
Address
, Barnet
Reference
None
Supplier is SME?
Yes
Allergan
Address
, Marlow
Reference
None
Organon Pharmaceuticals UK Ltd
Address
, London
Reference
None
Sandoz Ltd
Address
, Camberley
Reference
None
Supplier is SME?
Yes
Celltrion Healthcare United Kingdom Limited
Address
, Slough
Reference
None
Sobi (Swedish Orphan Biovitrum Ltd)
Address
, Cambridgeshire
Reference
None
Supplier is SME?
Yes
Merck Serono Limited
Address
, Feltham
Reference
None
Bristol Myers Squibb
Address
, Uxbridge
Reference
None
Eli Lilly & Company Ltd
Address
, Basingstoke
Reference
None
Vifor Pharma UK Ltd
Address
, London
Reference
None
Supplier is SME?
Yes
Merz
Address
, Hemel Hempstead
Reference
None
Supplier is SME?
Yes
Takeda UK Ltd
Address
, London
Reference
None
AstraZeneca
Address
, Luton
Reference
None
Ferring Pharmaceuticals Ltd
Address
, West Drayton
Reference
None
Supplier is SME?
Yes
Aventis Pharma ltd t/a Sanofi
Address
, Reading
Reference
None
Pharmacosmos UK Ltd
Address
, Reading
Reference
None
Supplier is SME?
Yes
Tetris Pharma Lts
Address
, Northampton
Reference
None
Supplier is SME?
Yes
Ipsen
Address
, Slough
Reference
None
Profile Pharma Ltd
Address
, Chichester
Reference
None
Supplier is SME?
Yes
CST Pharma Limited
Address
, Walsall
Reference
None
Supplier is SME?
Yes
Gilead Sciences Limited
Address
, Holborn
Reference
None
Morningside Pharmaeuticals
Address
, Northampton
Reference
None
Supplier is SME?
Yes
Chugai
Address
, Chiswick
Reference
None
Supplier is SME?
Yes
UCB
Address
, Slough
Reference
None
About the buyer
Contact name
Giorgie Rushton
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
GB
Share this notice
All content is available under the
